REALATED ARTICLES

Click on a word or phrase in our Tag Cloud and see all related articles listed below.

 

Current tag:

UK Chemical Industries’ Lessons From the Recession

Dr John Saul, past President of the British Chemical Industries Association on Issues For a Sustainable Future of the Sector

Dr John SaulApril 2011. The chemicals industry in the UK his coming out of some quite difficult times. How sustainable is recovery? In the exclusive interview with B2Bioworld Dr John Saul, past President of CIA provides an outlook on the future of the UK chemicals industry leveraging British Pound, US Dollar and Euro, while seeking opportunities within the UK, in the EU, and emerging countries. Demanding tasks lie ahead. While pharma is the draught horse of the UK chemicals industry, how competitive is the rest of it on a global scale? What is the strategy to reduce dependency on fossil energies and in which ways does it account for nuclear or renewable ones? How is REACH regulations viewed from within the country? Last not least, what are prospects that policy makers coherently attend to industry interests given a rather fragmented scene of lobbying organisations and preferences for the finance and banking sector?

Related Articles

Clariant & Süd-Chemie: “rather limited synergies”

Dr. Günter von Au, Designated Board Member Clariant AG and CEO Süd-Chemie AG

Fighting Crisis in the Chemicals Industry!

Giorgio Squinzi, CEO of Mapei SpA and past President of Italy’s Federchimica

Turkish Chemicals Industry: Opportunities and Threats

Timur Erk, President of TKSD on re-building Turkey’s chemicals industry

What Future for the Chemicals Industry?

Dr. Stefan Marcinowski, Member of the Board of Executive Directors of BASF SE



If you would like to read more, please proceed to the download section.

Important: After pressing "Buy this article (PayPal)" below you will be taken to the PaypPal checkout page. There you must press the orange "Return To BioBusinessMedia" button in order to download your article.
In buying this article you agree with our Terms & Conditions which you can consult here.

interview 8 pages

Paul Pomerantz: How to Ensure the Health of the Pharma Industry

Paul Pomerantz (C) DIA 2009Oktober 2009. Paul Pomerantz is designated Worldwide Executive Director of Drug Information Association (DIA). He will begin his tenure on December 1, 2009. In an interview with B2Bioworld Mr. Pomerantz outlines his approach and priorities of his new organisation. Includes breakdowns of membership and geographical representation of advisors.

 

 

 

 



If you would like to read more, please proceed to the download section.

Important: After pressing "Buy this article (PayPal)" below you will be taken to the PaypPal checkout page. There you must press the orange "Return To BioBusinessMedia" button in order to download your article.
In buying this article you agree with our Terms & Conditions which you can consult here.

enquired, exclusive, 2 pages

Novartis: Adhering to Values Pays off

Novartis continues to expand the biotech therapeutics pipeline / Focus on emerging markets

Dr. Daniel Vasella28-01-2009. Presenting financial results 2008 Novartis’ management board outlines its strategy, and comments on competitors. Largely overlooked are the donation programs and its impact on the firm and emerging pharmaceutical markets.

 

 

 

 

 

 



If you would like to read more, please proceed to the download section.

Important: After pressing "Buy this article (PayPal)" below you will be taken to the PaypPal checkout page. There you must press the orange "Return To BioBusinessMedia" button in order to download your article.
In buying this article you agree with our Terms & Conditions which you can consult here.

Edited 2 pages, advert free

Top 10 Tags

All Tags (2094)